Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Presentation TCT 2017

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Samir R. Kapadia, Ioanna Kosmidou

November 01, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Presenter: Daniel Burkhoff, Samir R. Kapadia, Patrick Klein

November 01, 2017

Presentation TCT 2017

Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Presenter: Daniel Burkhoff, Samir R. Kapadia, Toby Rogers

November 01, 2017

Presentation TCT 2017

First-in-Human Experience With Aortix Intra-aortic Pump

Presenter: Daniel Burkhoff, Samir R. Kapadia, Amit N Vora

November 01, 2017

Presentation TCT 2017

Therapeutic Force Transduction and Optimization of Intra-cardiac Blood Flow to Support Heart Function in Heart Failure Patients

Presenter: Daniel Burkhoff, Samir R. Kapadia, John Wilson

November 01, 2017

Presentation TCT 2017

Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) Multi-center Registry

Presenter: Daniel Burkhoff, Samir R. Kapadia, James M. McCabe

November 01, 2017

Presentation TCT 2017

Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center

Presenter: Daniel Burkhoff, Samir R. Kapadia, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

Percutaneous Suture-mediated Patent Foramen Ovale (PFO) Closure: Early Results With NobleStitchEL Device

Presenter: Daniel Burkhoff, Samir R. Kapadia, Achille Gaspardone

November 01, 2017

Presentation TCT 2017

Cathhelix: A Novel Trans-catheter Mitral Valve Repair System

Presenter: Daniel Burkhoff, Samir R. Kapadia, Bruno Scheller

November 01, 2017

$First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease$

Presentation TCT 2017

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo

November 01, 2017

Presentation TCT 2017

Case #3 Introduction: Degenerative MR With Flail Leaflet(S) in an Intermediate Clinical Risk Patient

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Olaf Franzen

October 31, 2017

Presentation TCT 2017

Case #2 Conclusion: How We Treated Functional MR With Multiple Jets in an Intermediate Clinical Risk Patient

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Roger J. Laham

October 31, 2017

Advertisement

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

First-in-Human Experience With Aortix Intra-aortic Pump

Therapeutic Force Transduction and Optimization of Intra-cardiac Blood Flow to Support Heart Function in Heart Failure Patients

Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) Multi-center Registry

Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Percutaneous Suture-mediated Patent Foramen Ovale (PFO) Closure: Early Results With NobleStitchEL Device

Cathhelix: A Novel Trans-catheter Mitral Valve Repair System

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Case #3 Introduction: Degenerative MR With Flail Leaflet(S) in an Intermediate Clinical Risk Patient

Case #2 Conclusion: How We Treated Functional MR With Multiple Jets in an Intermediate Clinical Risk Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content